These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8403629)

  • 1. Eosinophilia-myalgia syndrome: a clinicopathological study of four patients.
    Villanova M; De Clerck LS; Cras P; Ceuterick C; Van Marck E; Guazzi GC; Martin JJ
    Clin Neuropathol; 1993; 12(4):201-3. PubMed ID: 8403629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eosinophilia-myalgia syndrome: myopathic electrodiagnostic characteristics.
    Tanhehco JL; Wiechers DO; Golbus J; Neely SE
    Muscle Nerve; 1992 May; 15(5):561-7. PubMed ID: 1584247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophilia myalgia syndrome: absence of immunoglobulin reactivity suggests a cellular rather than humoral mechanism.
    Villanova M; De Clerck LS; Cras P; Guazzi GC; Martin JJ
    Acta Neurol Belg; 1994; 94(3):200-4. PubMed ID: 7976226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axonal neuropathy in eosinophilia-myalgia syndrome.
    Burns SM; Lange DJ; Jaffe I; Hays AP
    Muscle Nerve; 1994 Mar; 17(3):293-8. PubMed ID: 8107705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demyelinating polyneuropathy in eosinophilia-myalgia syndrome.
    Donofrio PD; Stanton C; Miller VS; Oestreich L; Lefkowitz DS; Walker FO; Ely EW
    Muscle Nerve; 1992 Jul; 15(7):796-805. PubMed ID: 1323757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [L-tryptophan-associated chronic eosinophilia-myalgia syndrome treated with cyclosporin].
    Schubert S; Trautmann F; Dreher R
    Z Rheumatol; 1992; 51(4):158-62. PubMed ID: 1414039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eosinophilia-myalgia syndrome: a recent syndrome serving as an alert to new diseases ahead.
    Sidransky H
    Mod Pathol; 1994 Sep; 7(7):806-10. PubMed ID: 7824518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eosinophilia-myalgia syndrome associated with ingestion of L-tryptophan.
    Keating JP; Wardill K; Viggiano J
    N Z Med J; 1992 Aug; 105(939):317. PubMed ID: 1386918
    [No Abstract]   [Full Text] [Related]  

  • 9. Immune-mediated mechanisms and immune activation of fibroblasts in the pathogenesis of eosinophilia-myalgia syndrome induced by L-tryptophan.
    Illa I; Dinsmore S; Dalakas MC
    Hum Pathol; 1993 Jul; 24(7):702-9. PubMed ID: 8100551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Eosinophilia-myalgia syndrome. Clinical aspects and follow-up of 10 patients].
    Mensing H; Schallreuter KU; Senff H; Steinkraus V
    Hautarzt; 1992 Jul; 43(7):436-40. PubMed ID: 1506202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Eosinophilia-myalgia syndrome].
    Reinauer S; Plewig G
    Hautarzt; 1991 Mar; 42(3):137-9. PubMed ID: 2055761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Eosinophilic fasciitis (Shulman syndrome). Differential diagnosis of chronic eosinophilia-myalgia syndrome after L-tryptophan administration].
    Schnabel A; Reusch M; Christophers E; Gross WL
    Internist (Berl); 1994 Jan; 35(1):63-6. PubMed ID: 8144322
    [No Abstract]   [Full Text] [Related]  

  • 13. Eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Analysis of four patients and implications for differential diagnosis and pathogenesis.
    Strongwater SL; Woda BA; Yood RA; Rybak ME; Sargent J; DeGirolami U; Smith TW; Varnis C; Allen S; Murphy K
    Arch Intern Med; 1990 Oct; 150(10):2178-86. PubMed ID: 2222105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A murine model of the eosinophilia-myalgia syndrome induced by 1,1'-ethylidenebis (L-tryptophan).
    Silver RM; Ludwicka A; Hampton M; Ohba T; Bingel SA; Smith T; Harley RA; Maize J; Heyes MP
    J Clin Invest; 1994 Apr; 93(4):1473-80. PubMed ID: 8163652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical improvement of the myopathy in eosinophilia-myalgia syndrome with steroids and rehabilitative therapy.
    Esper JJ; Nigro MA; Wishnow R; Barnett T; Perrotta AL; Richardson W
    J Am Osteopath Assoc; 1992 Aug; 92(8):1056-8. PubMed ID: 1429067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of polymyositis infiltrates using monoclonal antibodies to human leucocyte antigens.
    Rowe DJ; Isenberg DA; McDougall J; Beverley PC
    Clin Exp Immunol; 1981 Aug; 45(2):290-8. PubMed ID: 7032768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microangiopathy in the eosinophilia-myalgia syndrome.
    Smith SA; Roelofs RI; Gertner E
    J Rheumatol; 1990 Nov; 17(11):1544-50. PubMed ID: 2273500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eosinophilic perimyositis as the presenting feature of a monoclonal T-cell expansion.
    Dunand M; Lobrinus JA; Spertini O; Kuntzer T
    Muscle Nerve; 2005 May; 31(5):646-51. PubMed ID: 15770667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical analysis of HLA class II antigens and tumor infiltrating mononuclear cells in renal cell carcinoma: correlation with clinical and histopathological data.
    Brasanac D; Marković-Lipkovski J; Hadzi-Djokić J; Müller GA; Müller CA
    Neoplasma; 1999; 46(3):173-8. PubMed ID: 10613593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The immunoreactivity studies of the idiopathic inflammatory myopathy over the past three years in our laboratory].
    Hiruma S; Ohtsuka K; Satou T; Furuta T; Kimura M; Hashimoto S
    Rinsho Byori; 1998 Feb; 46(2):168-75. PubMed ID: 9528342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.